KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Goodwill (2016 - 2025)

Historic Goodwill for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to $18.7 billion.

  • Amgen's Goodwill rose 9.65% to $18.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $18.7 billion, marking a year-over-year increase of 9.65%. This contributed to the annual value of $18.6 billion for FY2024, which is 4.29% up from last year.
  • As of Q3 2025, Amgen's Goodwill stood at $18.7 billion, which was up 9.65% from $18.7 billion recorded in Q2 2025.
  • Amgen's 5-year Goodwill high stood at $18.7 billion for Q3 2025, and its period low was $14.7 billion during Q3 2021.
  • Its 5-year average for Goodwill is $16.6 billion, with a median of $15.5 billion in 2023.
  • In the last 5 years, Amgen's Goodwill dropped by 6.81% in 2021 and then soared by 2030.43% in 2024.
  • Quarter analysis of 5 years shows Amgen's Goodwill stood at $14.9 billion in 2021, then increased by 4.29% to $15.5 billion in 2022, then grew by 19.96% to $18.6 billion in 2023, then grew by 0.04% to $18.6 billion in 2024, then increased by 0.21% to $18.7 billion in 2025.
  • Its Goodwill stands at $18.7 billion for Q3 2025, versus $18.7 billion for Q2 2025 and $18.6 billion for Q1 2025.